A comprehensive view of Parasitic Diseases. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Gilead signs WHO’s Kigali Declaration to prevent, control, eliminate neglected tropical diseases; Gilead to continue to donate drugs to treat, eliminate parasitic disease visceral leishmaniasis in tropical, subtropical regions
Published: June 29, 2022 by SeeNews Pharmaceuticals
Novartis conducts Phase 1 trial of fast-acting oral malaria drug INE963, clinical trials on malaria drugs KAF156 ganaplacide, KAE609 cipargamin; malaria affects 200 million people annually, kills 500,000, with resistance to current therapies growing
Published: April 13, 2022 by Novartis AG
US federal court orders Bravo Packing to stop distributing allegedly adulterated pet food in violation of the Federal Food, Drug and Cosmetic Act after samples collected during FDA inspections were found to contain salmonella; company agrees to settle
Published: March 30, 2022 by U.S. Fed News
FDA approves Teva Pharmaceuticals’ ANDA 212485 for Ivermectin 0.5% antiparasitic OTC topical lotion in one formulation; two other OTC drugs have same active ingredient, dosage form, strength
Published: March 28, 2022 by US Food and Drug Administration News (CBNB Abstracts)
Merck KGaA announces donation of 1.5 billionth tablet of praziquantel in partnership with the WHO; medicine is a treatment for schistosomiasis, a parasitic disease most common in tropical regions
Published: January 24, 2022 by Merck KGaA

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count